PREECLAMPSIA BEYOND PREGNANCY: LONG-TERM CONSEQUENCES FOR MOTHER AND CHILD
PDF

Ключевые слова

preeclampsia, long-term outcomes, cardiovascular disease, chronic kidney disease, fetal programming.

Аннотация

Preeclampsia is a complex hypertensive disorder of pregnancy with systemic manifestations that extend far beyond delivery. Once considered a transient obstetric complication, preeclampsia is now recognized as a powerful predictor of future cardiovascular, renal, metabolic, and neurodevelopmental disease in both mother and offspring. Large-scale cohort studies and meta-analyses demonstrate that women with a history of preeclampsia have a two- to fourfold increased risk of chronic hypertension, ischemic heart disease, stroke, heart failure, and end-stage renal disease later in life [1–4]. Similarly, offspring exposed to preeclampsia in utero exhibit increased susceptibility to hypertension, metabolic syndrome, and neurodevelopmental disorders, supporting the developmental origins of health and disease hypothesis [5–7]. This review integrates epidemiologic, mechanistic, and clinical evidence to elucidate the long-term consequences of preeclampsia and proposes a framework for lifelong surveillance and prevention strategies for affected mothers and children.

PDF

Библиографические ссылки

Wu P, Haththotuwa R, Kwok CS, et al. Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. BMJ. 2017;359:j4984.

Bellamy L, Casas JP, Hingorani AD, Williams DJ. Preeclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. Lancet. 2007;369(9575):1773–1780.

Brown MC, Best KE, Pearce MS, et al. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Hypertension. 2013;62(4):681–689.

Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM. Preeclampsia and the risk of end-stage renal disease. N Engl J Med. 2008;359(8):800–809.

Barker DJP. The developmental origins of adult disease. J Am Coll Nutr. 2004;23(6 Suppl):588S–595S.

Davis EF, Lewandowski AJ, Aye C, et al. Clinical cardiovascular risk during young adulthood in offspring of hypertensive pregnancies. Circulation. 2015;132(10):951–959.

Maher GM, McCarthy FP, McCarthy CM, et al. Association of hypertensive disorders of pregnancy with risk of neurodevelopmental disorders in offspring. JAMA Psychiatry. 2018;75(8):809–819.

Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet. 2014;384(9947):1397–1407.

Garovic VD, August P. Preeclampsia and the future risk of hypertension. Hypertension. 2013;62(6):1002–1004.

Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta. 2009;30 Suppl A:S32–S37.

Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women. Circulation. 2011;123(11):1243–1262.

Redman CW, Sargent IL. Placental stress and pre-eclampsia: a revised view. Placenta. 2009;30 Suppl A:S38–S42.